Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.61 |
| ▸ | TNKS | O95271 | 1/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.61 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29426419 | 1.00 | NPSR1 (0.62) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL79074 | 1.00 | NPSR1 (0.62) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL9714866 | 1.00 | NPSR1 (0.62) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| Acetic Acid SCHEMBL9008656 | 0.90 | NPSR1 (0.53) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1510681 | 0.90 | IP6K1 (0.59) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL20546854 | 0.88 | KDM4E (0.55) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7505509 | 0.87 | MAOB (0.58) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6711401 | 0.87 | MAOB (0.58) | NPSR1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5599099 | 0.86 | CYP1A2 (0.61) | NPSR1MAOAMAOBKDM4EALDH1A1 | |
| SCHEMBL5599097 | 0.86 | CYP1A2 (0.61) | NPSR1MAOAMAOBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| CN-119505088-A | Thickening agent, oil displacement agent, and preparation method and application thereof | 天津市滨海新区环境创新研究院 | 2025-02-25 | — | — | CN | claimed |
| US-20230390195-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | DELPOR, INC. | 2023-12-07 | — | — | US | claimed |
| CN-114163313-B | Method for selectively synthesizing EZ-stilbene by coupling ruthenium-catalyzed aryl diazonium salt with cinnamic acid | 中山大学 | 2023-11-03 | — | — | CN | claimed |
| US-20220280494-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. | 2022-09-08 | — | — | US | claimed |
| EP-4021406-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | Delpor, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| CN-114438149-A | Method for synthesizing benzylisoquinoline alkaloid by constructing biological cascade reaction | 上海交通大学 | 2022-05-06 | — | — | CN | claimed |
| CN-114350326-A | Coolant, preparation method thereof, temperature-sensitive flocculent gel and aerosol fire extinguishing device | 湖北及安盾消防科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2021041730-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. (US) | 2021-03-04 | — | — | WO | claimed |
| US-20190224122-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | NATIONAL INSTITUTES OF HEALTH | 2019-07-25 | — | — | US | claimed |
| US-20020011584-A1 | Stable, aqueous compositions for treating surfaces, especially fabrics | THE PROCTOR & GAMBLE COMPANY | 2002-01-31 | — | — | US | claimed |
| US-20020010154-A1 | Compositions comprising cyclodextrin | THE PROCTER & GAMBLE COMPANY | 2002-01-24 | — | — | US | claimed |
| WO-2001088076-A1 | COMPOSITIONS COMPRISING CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-22 | — | — | WO | claimed |
| US-6289286-B1 | Surface regeneration of biosensors and characterization of biomolecules associated therewith | BIACORE AB (SE) | 2001-09-11 | — | — | US | claimed |
| WO-2001060961-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| EP-1082607-A1 | SURFACE REGENERATION OF BIOSENSORS | Biacore AB (SE) | 2001-03-14 | — | — | EP | claimed |
| WO-1999063333-A1 | SURFACE REGENERATION OF BIOSENSORS | BIACORE AB (SE) | 1999-12-09 | — | — | WO | claimed |
| EP-0861072-A2 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1998-09-02 | — | — | EP | claimed |
| WO-1996027369-A2 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-09-12 | — | — | WO | claimed |
| US-3984491-A | EPOXY RESIN MODIFIED WITH CINNAMIC, ALPHA-METHYLCINNAMIC AND COUMARIC ACIDS | TOKUYAMA SEKISUI KOGYO KABUSHIKI KAISHA (JA) | 1976-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010154-A1 | Compositions comprising cyclodextrin | FFAR4, FRG1, FGB | NPSR1 2912/4885HDAC3 2591/4885HDAC4 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.